1. Home
  2. AAPG vs FRSH Comparison

AAPG vs FRSH Comparison

Compare AAPG & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • FRSH
  • Stock Information
  • Founded
  • AAPG 2009
  • FRSH 2010
  • Country
  • AAPG China
  • FRSH United States
  • Employees
  • AAPG N/A
  • FRSH N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • FRSH EDP Services
  • Sector
  • AAPG Health Care
  • FRSH Technology
  • Exchange
  • AAPG Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • AAPG 3.6B
  • FRSH 3.7B
  • IPO Year
  • AAPG 2025
  • FRSH 2021
  • Fundamental
  • Price
  • AAPG $34.30
  • FRSH $11.67
  • Analyst Decision
  • AAPG Strong Buy
  • FRSH Buy
  • Analyst Count
  • AAPG 3
  • FRSH 16
  • Target Price
  • AAPG $49.00
  • FRSH $19.44
  • AVG Volume (30 Days)
  • AAPG 8.1K
  • FRSH 4.2M
  • Earning Date
  • AAPG 11-19-2025
  • FRSH 11-05-2025
  • Dividend Yield
  • AAPG N/A
  • FRSH N/A
  • EPS Growth
  • AAPG N/A
  • FRSH N/A
  • EPS
  • AAPG N/A
  • FRSH N/A
  • Revenue
  • AAPG $54,524,554.00
  • FRSH $810,640,000.00
  • Revenue This Year
  • AAPG N/A
  • FRSH $17.01
  • Revenue Next Year
  • AAPG $368.64
  • FRSH $13.02
  • P/E Ratio
  • AAPG N/A
  • FRSH N/A
  • Revenue Growth
  • AAPG N/A
  • FRSH 18.18
  • 52 Week Low
  • AAPG $16.50
  • FRSH $10.51
  • 52 Week High
  • AAPG $48.45
  • FRSH $19.77
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • FRSH 53.93
  • Support Level
  • AAPG $30.93
  • FRSH $10.52
  • Resistance Level
  • AAPG $34.31
  • FRSH $12.26
  • Average True Range (ATR)
  • AAPG 0.81
  • FRSH 0.42
  • MACD
  • AAPG 0.26
  • FRSH 0.14
  • Stochastic Oscillator
  • AAPG 85.99
  • FRSH 68.39

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: